Skip to main content
Smart Investors Daily
US

NYSE · USPH

U.S. Physical Therapy, Inc.

Healthcare · Medical - Care Facilities

$88.53

Down-$0.20 (-0.23%)

Updated Oct 25, 2026, 2:57 PM

SID Score

5.4/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.22B
P/E ratio
36.55
Dividend yield
2.03%
52-week range
$58.19 – $88.87
Volume
102.91K
Avg. volume
170.58K

Price performance · USPH

USPH price history

1M range · 20 trading sessions · Daily adjusted prices

Prices through Oct 23, 2026

USPH closed at $88.53 after 20 trading sessions, up 2.83% for the selected period.

Last close
$88.53
Period change
+2.83%
Period low
$82.60
Period high
$88.73
Daily close
View OHLC price history
USPH OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 23, 2026$88.16$88.86$85.44$88.53102.91K
Oct 22, 2026$86.71$88.87$86.30$88.73129.98K
Oct 21, 2026$86.61$87.75$79.7601$86.28117.41K
Oct 20, 2026$84.20$87.17$84.20$87.02177.25K
Oct 19, 2026$85.50$86.35$83.83$83.91133.43K
Oct 16, 2026$86.37$86.66$84.90$85.71245.99K
Oct 15, 2026$85.91$87.41$84.18$85.98302.8K
Oct 14, 2026$84.96$86.17$82.26$84.91119.8K
Oct 13, 2026$86.33$86.69$85.36$85.44104.09K
Oct 12, 2026$84.27$86.32$84.27$85.93104.45K
Oct 9, 2026$84.09$85.55$83.4625$84.67143.47K
Oct 8, 2026$82.74$84.385$82.51$83.52177.33K
Oct 7, 2026$82.81$84.97$82.73$82.96233.95K
Oct 6, 2026$84.72$85.85$82.80$83.63190.47K
Oct 5, 2026$84.13$84.57$82.87$83.96243.92K
Oct 2, 2026$83.21$84.685$82.55$83.72239.78K
Oct 1, 2026$85.58$85.915$82.60$82.60140.76K
Sep 30, 2026$86.46$87.22$85.72$85.73137.61K
Sep 29, 2026$85.66$86.39$84.625$86.15208.18K
Sep 28, 2026$85.21$87.37$84.88$86.09196.53K

Latest USPH news

The latest Smart Investors Daily articles mentioning USPH.

USPH research

Overview

Company profile and research snapshot.

Company profile

US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$98.00
Implied upside
—
Analysts
13
USPH recent ratings
DateFirmRatingTarget
Sep 11, 2026JP MorganOverweight—
Aug 10, 2026Barrington ResearchOutperform—
Jun 24, 2026CitizensMarket Outperform—
May 13, 2026Barrington ResearchOutperform—
May 8, 2026CitizensMarket Outperform—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 13, 2026

3 Profitable Stocks We Find Risky

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.

Yahoo · Sep 30, 2026

3 Cash-Producing Stocks with Questionable Fundamentals

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.

Yahoo · Sep 21, 2026

U.S. Physical Therapy Announces the Appointment of New Board Member Myra Davis

HOUSTON, September 21, 2026--U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that its Board of Directors (the "Board") approved the appointment of Ms. Myra Davis to serve as a member of the Board, effective October 1, 2026.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.